ConductScience.org, home

Paper41369447

Therapeutic Potential of Nanoscale Metal-Organic Frameworks in Hepatocellular Carcinoma.

Tutunchi H and 2 others. Nanomaterials (Basel), 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Therapeutic Potential of Nanoscale Metal-Organic Frameworks in Hepatocellular Carcinoma. Papers, record 41369447. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41369447

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic Potential of Nanoscale Metal-Organic Frameworks in Hepatocellular Carcinoma.
PubMed
Journal
Nanomaterials (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-12-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tutunchi HHeldahttps://orcid.org/0000-0002-4795-1757
2Nabipour HHafezeh
3Rohani SSohrabhttps://orcid.org/0000-0002-1667-1736

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References77

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131746153Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.Adv Healthc Mater2020https://conductscience.org/library/papers/31746153PubMed
221115576The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.Oncologist2010https://conductscience.org/library/papers/21115576PubMed
340006592Drug Delivery Systems Based on Metal-Organic Frameworks for Tumor Immunotherapy.Pharmaceutics2025https://conductscience.org/library/papers/40006592PubMed
440890797Nanoscale metal-organic frameworks as a versatile platform for synergistic combination tumor therapy.J Nanobiotechnology2025https://conductscience.org/library/papers/40890797PubMed
533283806Multifunctional metal-organic framework heterostructures for enhanced cancer therapy.Chem Soc Rev2021https://conductscience.org/library/papers/33283806PubMed
640734635Recent Developments in Nanoparticle-Hydrogel Hybrid Materials for Controlled Release.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40734635PubMed
733277608Engineering precision nanoparticles for drug delivery.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33277608PubMed
839852047Recent Advances in Metal-Organic Framework-Based Anticancer Hydrogels.Gels2025https://conductscience.org/library/papers/39852047PubMed
932909732A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence.ACS Nano2020https://conductscience.org/library/papers/32909732PubMed
1037631285A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies.Pharmaceutics2023https://conductscience.org/library/papers/37631285PubMed
1134255347Radiation therapy-associated toxicity: Etiology, management, and prevention.CA Cancer J Clin2021https://conductscience.org/library/papers/34255347PubMed
1232151012Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancer.Pharmaceutics2020https://conductscience.org/library/papers/32151012PubMed
1331996879A natural polysaccharide mediated MOF-based Ce6 delivery system with improved biological properties for photodynamic therapy.J Mater Chem B2020https://conductscience.org/library/papers/31996879PubMed
1437569377A Comprehensive Review of Inorganic Sonosensitizers for Sonodynamic Therapy.Int J Mol Sci2023https://conductscience.org/library/papers/37569377PubMed
1531194910Cancer-Cell-Activated Photodynamic Therapy Assisted by Cu(II)-Based Metal-Organic Framework.ACS Nano2019https://conductscience.org/library/papers/31194910PubMed
1638572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1740142970Anti-Tumor Strategies of Photothermal Therapy Combined with Other Therapies Using Nanoplatforms.Pharmaceutics2025https://conductscience.org/library/papers/40142970PubMed
1839418638Applications of Metal-Organic Frameworks (MOFs) in Drug Delivery, Biosensing, and Therapy: A Comprehensive Review.Langmuir2024https://conductscience.org/library/papers/39418638PubMed
1936386143Nanosystems for chemodynamic based combination therapy: Strategies and recent advances.Front Pharmacol2022https://conductscience.org/library/papers/36386143PubMed
2036860309Recent progress of hydrogel-based local drug delivery systems for postoperative radiotherapy.Front Oncol2023https://conductscience.org/library/papers/36860309PubMed

See all 77 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42644988Bioactive Hydrogel-MOF Composites as Resistance-Modulating Wound Interfaces: Molecular Mechanisms and Rational Design for Chronic Wound Management.Gels2026https://conductscience.org/library/papers/42644988

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41369447

GET https://conductscience.org/api/papers/v1/41369447/references?page=2